INNOVATIVE DESIGN LABS INC — Department of Health and Human Services SBIR Phase II: Y
INNOVATIVE DESIGN LABS INC — SBIR Phase II award from Department of Health and Human Services.
Phase II SBIR prototype / development signal
- Phase II is where Department of Health and Human Services funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- Obligated amount $1,281,557 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
- Topic code Y links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.
- Amount
- $1,281,557
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase II
- Topic
- Y
- Solicitation
- PAS19-316
- NAICS
- —
- Place of performance
- MN
- Period
- 2022-09-15 → 2024-08-31
Description
Project Summary/Abstract Proposed is a sleep monitoring system specifically designed for care providers of persons with Alzheimer’s disease and Alzheimer’s Disease Related Dementias (AD/ADRD) to monitor sleep disturbances and trends. Significance: Studies indicate that approximately 1 in 3 patients with AD/ADRD suffer from sleep and other nighttime disturbances such as insomnia and disruption of sleep, wandering, day/night confusion, repeatedly leaving bed, nightmares, and hallucinations. Sleep disturbances often lead to reduced health and lower quality of life for persons with AD/ADRD and in Long Term Care (LTC) settings place burden on staff. Nearly half of all people in LTC settings have a diagnosis of AD/ADRD. Unfortunately, clinical providers and staff in LTCs are limited in their ability to identify and treat these conditions as current methods of sleep quality assessment are either inaccurate, time consuming, or inappropriate for use with those who have AD/ADRD. Hypothesis: We hypothesize that a system which allows for practical, long-term monitoring of sleep quality metrics for patients with AD/ADRD will lead to greater documentation of sleep problems, greater prescribing of appropriate nonpharmacological treatment, and improvements in sleep quality and daytime inactivity. Specific Aims: To transition the Phase I prototype to a production ready product and evaluate the efficacy of the system in Phase II IDL will 1) Create production-ready system with updated hardware, firmware, and mechanical design 2) Create cloud-enabled backend, implement web / mobile interfaces, and refine sleep metrics and 3) Evaluate system’s real-world feasibility, acceptability, and utility in a before-after clinical trial.